Analyst Consensus ?
ConsensusBuy95 ratings
Bullish7376.8%
Neutral2021.1%
Bearish22.1%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Salesforce, Inc. analyst ratings
Salesforce, Inc. (CRM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$247.72Current
$119Low
$273.82Average
$675High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Needham | Buy | Buy | Maintain | Sep 2, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Sep 2, 2026 |
| BTIG | Buy | Buy | Maintain | Sep 2, 2026 |
| TD Cowen | Buy | Buy | Maintain | Sep 1, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 31, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Aug 27, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 27, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 27, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 27, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 27, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 27, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Aug 27, 2026 |
| Macquarie | Neutral | Neutral | Maintain | Aug 27, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 27, 2026 |
| Jefferies | Buy | Buy | Maintain | Aug 27, 2026 |
| Guggenheim | Buy | Buy | Maintain | Aug 27, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 27, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Aug 27, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Aug 27, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 27, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Aug 27, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 27, 2026 |
| Bernstein | Underperform | Underperform | Maintain | Aug 27, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 27, 2026 |
| Keybanc | Overweight | Downgrade | Jul 9, 2026 | |
| Wedbush | Outperform | Outperform | Maintain | May 28, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | May 28, 2026 |
| B. Riley Securities | Buy | Buy | Maintain | May 28, 2026 |
| Northland Capital Markets | Market Perform | Market Perform | Maintain | Mar 10, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 26, 2026 |
| Roth Capital | Buy | Buy | Maintain | Feb 26, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Dec 4, 2025 |
| Baird | Outperform | Outperform | Maintain | Dec 4, 2025 |
| B of A Securities | Buy | Buy | Maintain | Nov 17, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 17, 2025 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | May 30, 2025 |
| WestPark Capital | Buy | Buy | Maintain | May 29, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | May 29, 2025 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Mar 17, 2025 |
| Loop Capital | Hold | Hold | Maintain | Feb 27, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Feb 24, 2025 |
| Erste Group | Buy | Hold | Upgrade | Nov 19, 2024 |
| Phillip Securities | Accumulate | Buy | Maintain | Aug 30, 2024 |
| Roth MKM | Buy | Buy | Maintain | Aug 29, 2024 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Aug 29, 2024 |
| Wolfe Research | Outperform | Outperform | Maintain | Apr 16, 2024 |
| Societe Generale | Hold | Buy | Downgrade | Jun 1, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 21, 2023 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Jan 13, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Dec 5, 2022 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Nov 17, 2022 |
| Cleveland Research | Neutral | Buy | Downgrade | Sep 28, 2022 |
| CICC | Outperform | Outperform | Maintain | May 9, 2022 |
| Redburn Partners | Buy | Buy | Maintain | Jun 28, 2021 |
| KGI Securities | Neutral | Neutral | Maintain | Jun 2, 2021 |
| CFRA | Strong Buy | Strong Buy | Maintain | Jun 1, 2020 |
| Rosenblatt | Sell | Sell | Maintain | May 5, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Aug 23, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Aug 23, 2019 |
| Nomura | Buy | Buy | Maintain | Aug 23, 2019 |
| Compass Point | Buy | Buy | Maintain | Aug 13, 2019 |
| Exane BNP Paribas | Outperform | Outperform | Maintain | Mar 29, 2019 |
| Pivotal Research | Buy | Hold | Upgrade | Jan 7, 2019 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 21, 2018 |
| Argus | Buy | Buy | Maintain | Aug 31, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| Monness Crespi Hardt | Buy | Buy | Maintain | Apr 11, 2018 |
| Bank of America | Buy | Buy | Maintain | Nov 8, 2017 |
| Moffett Nathanson | Buy | Buy | Maintain | Sep 6, 2017 |
| Benchmark | Outperform | Outperform | Maintain | Apr 27, 2017 |
| Drexel Hamilton | Buy | Buy | Maintain | Dec 19, 2016 |
| OTR Global | Positive | Mixed | Upgrade | Nov 15, 2016 |
| Wunderlich Securities | Buy | Buy | Maintain | Sep 1, 2016 |
| Wunderlich | Buy | Buy | Maintain | Sep 1, 2016 |
| MKM Partners | Buy | Buy | Maintain | May 19, 2016 |
| FBN Securities | Outperform | Outperform | Maintain | May 19, 2016 |
| Brean Capital | Buy | Buy | Maintain | May 19, 2016 |
| CLSA | Buy | Outperform | Maintain | Feb 10, 2016 |
| Pacific Crest | Overweight | Overweight | Maintain | Nov 19, 2015 |
| Lake Street | Buy | Buy | Maintain | Nov 9, 2015 |
| BTIG Research | Buy | Buy | Maintain | Sep 10, 2015 |
| Northland Securities | Outperform | Outperform | Maintain | Jul 8, 2015 |
| Susquehanna | Positive | Positive | Maintain | May 21, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | May 20, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Oct 3, 2014 |
| D.A. Davidson | Neutral | Neutral | Maintain | Oct 2, 2014 |
| B. Riley | Neutral | Neutral | Maintain | May 16, 2014 |
| Barrington Research | Outperform | Outperform | Maintain | Feb 26, 2014 |
| Janney Capital | Neutral | Neutral | Maintain | Oct 22, 2013 |
| Argus Capital | Buy | Buy | Maintain | Oct 17, 2013 |
| First Analysis | Overweight | Overweight | Maintain | Aug 20, 2013 |
| Global Equities Research | Overweight | Overweight | Maintain | Aug 16, 2013 |
| Maxim Group | Buy | Buy | Maintain | Jan 29, 2013 |
| Longbow Research | Neutral | Neutral | Maintain | Dec 14, 2012 |
| ThinkEquity | Buy | Buy | Maintain | Jul 13, 2012 |
| Bank oferica | Buy | Buy | Maintain | Feb 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $247.72. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $315 | $258.11 | +27.2% | Sep 2, 2026 |
| Monness | Brian White | $266 | $249.5 | +7.4% | Aug 27, 2026 |
| Oppenheimer | Brian Schwartz | $275 | $205.62 | +11.0% | Aug 27, 2026 |
| D.A. Davidson | Gil Luria | $200 | $205.62 | -19.3% | Aug 27, 2026 |
| Deutsche Bank | Analyst unavailable | $315 | $209.06 | +27.2% | Aug 25, 2026 |
| Monness | Brian White | $222 | $193.76 | -10.4% | Aug 13, 2026 |
| Cantor Fitzgerald | Matthew VanVliet | $250 | $179.52 | +0.9% | May 28, 2026 |
| Piper Sandler | Billy Fitzsimmons | $215 | $179.7 | -13.2% | May 28, 2026 |
| Roth Capital | Richard Baldry | $325 | $177.51 | +31.2% | May 28, 2026 |
| KeyBanc | Jackson Ader | $290 | $178.8 | +17.1% | May 28, 2026 |
| Truist Financial | Terry Tillman | $280 | $199.84 | +13.0% | Feb 26, 2026 |
| Oppenheimer | Brian Schwartz | $250 | $191.75 | +0.9% | Feb 26, 2026 |
| Goldman Sachs | Gabriela Borges | $281 | $191.75 | +13.4% | Feb 26, 2026 |
| BMO Capital | Keith Bachman | $235 | $187.34 | -5.1% | Feb 20, 2026 |
| Mizuho Securities | Gregg Moskowitz | $340 | $261.02 | +37.3% | Dec 10, 2025 |
| UBS | Karl Keirstead | $260 | $247.92 | +5.0% | Dec 4, 2025 |
| RBC Capital | Rishi Jaluria | $250 | $247.87 | +0.9% | Dec 4, 2025 |
| Needham | Scott Berg | $400 | $238.72 | +61.5% | Dec 4, 2025 |
| Oppenheimer | Brian Schwartz | $300 | $230.66 | +21.1% | Dec 1, 2025 |
| Roth Capital | Analyst unavailable | $395 | $244.01 | +59.5% | Sep 4, 2025 |
| UBS | Keith Weiss | $404 | $259.5 | +63.1% | Jun 18, 2025 |
| BMO Capital | Keith Bachman | $350 | $277.03 | +41.3% | May 28, 2025 |
| UBS | Brad Sills | $350 | $283.42 | +41.3% | May 22, 2025 |
| Cantor Fitzgerald | Carter Gould | $210 | $250.48 | -15.2% | Apr 23, 2025 |
| Piper Sandler | Brent Bracelin | $405 | $326.84 | +63.5% | Jan 21, 2025 |
| CFRA | Aaron Siegel | $380 | $331.01 | +53.4% | Dec 2, 2024 |
| BMO Capital | Keith Bachman | $385 | $326.69 | +55.4% | Nov 15, 2024 |
| CFRA | Aaron Siegel | $343 | $291.11 | +38.5% | Oct 17, 2024 |
| Northland Securities | Nehal Chokshi | $400 | $280.06 | +61.5% | Oct 2, 2024 |
| Piper Sandler | Brent Bracelin | $325 | $264.21 | +31.2% | Sep 24, 2024 |
| Bank of America Securities | Brad Sills | $325 | $261.95 | +31.2% | Sep 20, 2024 |
| Robert W. Baird | Rob Oliver | $315 | $265.99 | +27.2% | Sep 20, 2024 |
| Barclays | Raimo Lenschow | $305 | $252.43 | +23.1% | Sep 19, 2024 |
| Goldman Sachs | Kash Rangan | $325 | $253.37 | +31.2% | Sep 12, 2024 |
| Jefferies | Brent Thill | $350 | $242.66 | +41.3% | Sep 6, 2024 |
| Needham | Scott Berg | $345 | $246.12 | +39.3% | Sep 6, 2024 |
| Loop Capital Markets | Keith Bachman | $305 | $259.41 | +23.1% | Aug 29, 2024 |
| Truist Financial | Terry Tillman | $300 | $218.01 | +21.1% | May 30, 2024 |
| CFRA | Aaron Siegel | $300 | $218.01 | +21.1% | May 30, 2024 |
| BMO Capital | Keith Bachman | $265 | $218.22 | +7.0% | May 30, 2024 |
| Roth Capital | Richard Baldry | $335 | $271.62 | +35.2% | May 30, 2024 |
| Oppenheimer | Brian Schwartz | $280 | $218.18 | +13.0% | May 30, 2024 |
| Mizuho Securities | Gregg Moskowitz | $300 | $271.62 | +21.1% | May 30, 2024 |
| Goldman Sachs | Kash Rangan | $315 | $271.62 | +27.2% | May 30, 2024 |
| Evercore ISI | Kirk Materne | $330 | $269.83 | +33.2% | May 29, 2024 |
| RBC Capital | Rishi Jaluria | $350 | $278.57 | +41.3% | May 24, 2024 |
| Wells Fargo | Michael Turrin | $300 | $277.87 | +21.1% | May 23, 2024 |
| Oppenheimer | Brian Schwartz | $325 | $283.82 | +31.2% | May 23, 2024 |
| Goldman Sachs | Kash Rangan | $345 | $286.77 | +39.3% | May 20, 2024 |
| BMO Capital | Keith Bachman | $335 | $276.64 | +35.2% | Apr 16, 2024 |
| Wedbush | Daniel Ives | $325 | $303.07 | +31.2% | Feb 29, 2024 |
| Morgan Stanley | Keith Weiss | $350 | $300.39 | +41.3% | Feb 26, 2024 |
| Evercore ISI | Kirk Materne | $290 | $251.9 | +17.1% | Nov 30, 2023 |
| Needham | Mike Cikos | $675 | $230.35 | +172.5% | Nov 30, 2023 |
| Piper Sandler | Brent Bracelin | $232 | $230.46 | -6.3% | Nov 29, 2023 |
| Loop Capital Markets | Keith Bachman | $252 | $224.5 | +1.7% | Nov 21, 2023 |
| Needham | Scott Berg | $250 | $221.96 | +0.9% | Aug 31, 2023 |
| Piper Sandler | Brent Bracelin | $248 | $213.88 | +0.1% | Aug 30, 2023 |
| BMO Capital | Keith Bachman | $255 | $226.79 | +2.9% | Jul 12, 2023 |
| Oppenheimer | Brian Schwartz | $235 | $214.16 | -5.1% | Jun 1, 2023 |
| Wedbush | Daniel Ives | $220 | $188.6 | -11.2% | Mar 2, 2023 |
| Atlantic Equities | Analyst unavailable | $140 | $147.76 | -43.5% | Jan 13, 2023 |
| Bernstein | Mark Moerdler | $119 | $147.44 | -52.0% | Jan 11, 2023 |
| Piper Sandler | Analyst unavailable | $171 | $140.51 | -31.0% | Jan 9, 2023 |
| Morgan Stanley | Analyst unavailable | $228 | $128.04 | -8.0% | Dec 19, 2022 |
| Robert W. Baird | Rob Oliver | $150 | $130.48 | -39.4% | Dec 8, 2022 |
| Citigroup | Tyler Radke | $164 | $133.28 | -33.8% | Dec 5, 2022 |
| Credit Suisse | Analyst unavailable | $225 | $144.56 | -9.2% | Dec 5, 2022 |
| Wells Fargo | Michael Turrin | $175 | $143.83 | -29.4% | Dec 1, 2022 |
| Jefferies | Analyst unavailable | $230 | $145.16 | -7.2% | Dec 1, 2022 |
| Canaccord Genuity | Analyst unavailable | $180 | $145.16 | -27.3% | Dec 1, 2022 |
| Truist Financial | Analyst unavailable | $210 | $145.19 | -15.2% | Dec 1, 2022 |
| Cowen & Co. | Analyst unavailable | $195 | $144.9 | -21.3% | Dec 1, 2022 |
| Wedbush | Analyst unavailable | $200 | $144.15 | -19.3% | Dec 1, 2022 |
| Deutsche Bank | Analyst unavailable | $200 | $144.12 | -19.3% | Dec 1, 2022 |
| Barclays | Analyst unavailable | $180 | $144.12 | -27.3% | Dec 1, 2022 |
| Morgan Stanley | Analyst unavailable | $250 | $144.44 | +0.9% | Dec 1, 2022 |
| BMO Capital | Analyst unavailable | $172 | $143.98 | -30.6% | Dec 1, 2022 |
| J.P. Morgan | Analyst unavailable | $200 | $145.08 | -19.3% | Dec 1, 2022 |
| RBC Capital | Analyst unavailable | $200 | $160.25 | -19.3% | Dec 1, 2022 |
| Atlantic Equities | Analyst unavailable | $200 | $160.25 | -19.3% | Dec 1, 2022 |
| UBS | Analyst unavailable | $162 | $160.25 | -34.6% | Dec 1, 2022 |
| Raymond James | Analyst unavailable | $200 | $160.25 | -19.3% | Dec 1, 2022 |
| Oppenheimer | Analyst unavailable | $185 | $160.25 | -25.3% | Dec 1, 2022 |
| Barclays | Raimo Lenschow | $193 | $151.68 | -22.1% | Nov 30, 2022 |
| Wells Fargo | Analyst unavailable | $190 | $144.85 | -23.3% | Nov 22, 2022 |
| Jefferies | Brent Thill | $250 | $150.15 | +0.9% | Sep 22, 2022 |
| JMP Securities | Patrick Walravens | $250 | $150.15 | +0.9% | Sep 22, 2022 |
| RBC Capital | Rishi Jaluria | $235 | $150.15 | -5.1% | Sep 22, 2022 |
| BMO Capital | Keith Bachman | $207 | $170.31 | -16.4% | Aug 25, 2022 |
| Raymond James | Brian Peterson | $202 | $169.21 | -18.5% | Aug 25, 2022 |
| Wedbush | Nick Setyan | $264 | $180.01 | +6.6% | Aug 25, 2022 |
| BMO Capital | Keith Bachman | $207 | $173.91 | -16.4% | Aug 25, 2022 |
| Stifel Nicolaus | J. Parker Lane | $200 | $180.01 | -19.3% | Aug 25, 2022 |
| Evercore ISI | Kirk Materne | $225 | $180.01 | -9.2% | Aug 25, 2022 |
| JMP Securities | Patrick Walravens | $250 | $173.91 | +0.9% | Aug 25, 2022 |
| J.P. Morgan | Mark Murphy | $245 | $173.91 | -1.1% | Aug 25, 2022 |
| Piper Sandler | Brent Bracelin | $200 | $180.01 | -19.3% | Aug 25, 2022 |
| RBC Capital | Rishi Jaluria | $235 | $180.01 | -5.1% | Aug 25, 2022 |
| Wells Fargo | Michael Turrin | $220 | $180.01 | -11.2% | Aug 25, 2022 |
| Wedbush | Daniel Ives | $215 | $173.91 | -13.2% | Aug 25, 2022 |
| Robert W. Baird | Robert Oliver | $230 | $180.01 | -7.2% | Aug 25, 2022 |
| Citigroup | Tyler Radke | $179 | $180.01 | -27.7% | Aug 25, 2022 |
| Bank of America Securities | Bradley Sills | $210 | $180.01 | -15.2% | Aug 25, 2022 |
| Piper Sandler | Brent Bracelin | $200 | $173.91 | -19.3% | Aug 25, 2022 |
| Societe Generale | Richard Nguyen | $235 | $173.91 | -5.1% | Aug 25, 2022 |
| Wells Fargo | Michael Turrin | $220 | $173.91 | -11.2% | Aug 25, 2022 |
| Morgan Stanley | Keith Weiss | $273 | $190.09 | +10.2% | Aug 16, 2022 |
| Credit Suisse | Phil Winslow | $315 | $184.91 | +27.2% | Jun 4, 2022 |
| BMO Capital | Keith Bachman | $225 | $160.24 | -9.2% | Jun 1, 2022 |
| J.P. Morgan | Mark Murphy | $275 | $160.24 | +11.0% | Jun 1, 2022 |
| Jefferies | Brent Thill | $260 | $176.07 | +5.0% | Jun 1, 2022 |
| JMP Securities | Patrick Walravens | $250 | $176.07 | +0.9% | Jun 1, 2022 |
| Barclays | Raimo Lenschow | $218 | $176.07 | -12.0% | Jun 1, 2022 |
| Citigroup | Tyler Radke | $192 | $176.07 | -22.5% | Jun 1, 2022 |
| J.P. Morgan | Mark Murphy | $275 | $176.07 | +11.0% | Jun 1, 2022 |
| Wells Fargo | Michael Turrin | $235 | $160.24 | -5.1% | Jun 1, 2022 |
| Wedbush | Daniel Ives | $225 | $176.07 | -9.2% | Jun 1, 2022 |
| RBC Capital | Rishi Jaluria | $235 | $160.24 | -5.1% | Jun 1, 2022 |
| BMO Capital | Keith Bachman | $225 | $176.07 | -9.2% | Jun 1, 2022 |
| Robert W. Baird | Robert Oliver | $260 | $176.07 | +5.0% | Jun 1, 2022 |
| Stifel Nicolaus | J. Parker Lane | $250 | $176.07 | +0.9% | Jun 1, 2022 |
| Monness | Brian White | $225 | $176.07 | -9.2% | Jun 1, 2022 |
| Piper Sandler | Brent Bracelin | $250 | $176.07 | +0.9% | Jun 1, 2022 |
| RBC Capital | Rishi Jaluria | $235 | $176.07 | -5.1% | Jun 1, 2022 |
| Oppenheimer | Brian Schwartz | $205 | $165.1 | -17.2% | May 31, 2022 |
| Jefferies | Brent Thill | $260 | $160.32 | +5.0% | May 24, 2022 |
| Barclays | Raimo Lenschow | $208 | $159.65 | -16.0% | May 21, 2022 |
| Mizuho Securities | Gregg Moskowitz | $225 | $158.26 | -9.2% | May 19, 2022 |
| Morgan Stanley | Keith Weiss | $291 | $166.91 | +17.5% | May 16, 2022 |
| KeyBanc | Michael Turits | $223 | $175.94 | -10.0% | May 1, 2022 |
| Jefferies | Brent Thill | $330 | $170.84 | +33.2% | Apr 25, 2022 |
| Robert W. Baird | Robert Oliver | $300 | $184.82 | +21.1% | Apr 21, 2022 |
| Piper Sandler | Brent Bracelin | $330 | $204.75 | +33.2% | Mar 3, 2022 |
| Stifel Nicolaus | J. Parker Lane | $300 | $210.39 | +21.1% | Mar 2, 2022 |
| UBS | Karl Keirstead | $225 | $210.39 | -9.2% | Mar 2, 2022 |
| Citigroup | Tyler Radke | $233 | $210.39 | -5.9% | Mar 2, 2022 |
| J.P. Morgan | Mark Murphy | $316 | $210.39 | +27.6% | Mar 2, 2022 |
| Bank of America Securities | Bradley Sills | $300 | $210.39 | +21.1% | Mar 2, 2022 |
| RBC Capital | Rishi Jaluria | $325 | $210.39 | +31.2% | Mar 2, 2022 |
| Evercore ISI | Kirk Materne | $300 | $210.39 | +21.1% | Mar 2, 2022 |
| BMO Capital | Keith Bachman | $260 | $210.39 | +5.0% | Mar 2, 2022 |
| Goldman Sachs | Kash Rangan | $360 | $208.89 | +45.3% | Mar 1, 2022 |
| Barclays | Raimo Lenschow | $275 | $208.89 | +11.0% | Mar 1, 2022 |
| Jefferies | Brent Thill | $360 | $208.89 | +45.3% | Mar 1, 2022 |
| Deutsche Bank | Brad Zelnick | $300 | $208.89 | +21.1% | Mar 1, 2022 |
| Morgan Stanley | Keith Weiss | $360 | $210.53 | +45.3% | Feb 28, 2022 |
| Cowen & Co. | Derrick Wood | $285 | $210.53 | +15.0% | Feb 28, 2022 |
| Stifel Nicolaus | Parker Lane | $350 | $208.09 | +41.3% | Feb 26, 2022 |
| Wells Fargo | Michael Turrin | $265 | $204.29 | +7.0% | Feb 24, 2022 |
| Mizuho Securities | Gregg Moskowitz | $295 | $196.84 | +19.1% | Feb 20, 2022 |
| Goldman Sachs | Kash Rangan | $340 | $196.84 | +37.3% | Feb 18, 2022 |
| Loop Capital Markets | Yun Kim | $225 | $216.97 | -9.2% | Feb 7, 2022 |
| Barclays | Raimo Lenschow | $290 | $231.23 | +17.1% | Jan 16, 2022 |
| UBS | Karl Keirstead | $265 | $227.67 | +7.0% | Jan 5, 2022 |
| Truist Financial | Terry Tillman | $330 | $251.5 | +33.2% | Dec 1, 2021 |
| Atlantic Equities | Peter Sazel | $360 | $296.84 | +45.3% | Nov 22, 2021 |
| Norddeutsche Landesbank | Wolfgang Donie | $275 | $254.37 | +11.0% | Sep 14, 2021 |
| Societe Generale | Richard Nguyen | $321 | $266.53 | +29.6% | Aug 27, 2021 |
| Roth Capital | Richard Baldry | $242 | $267.79 | -2.3% | Aug 26, 2021 |
| Wolfe Research | Alex Zukin | $300 | $267.79 | +21.1% | Aug 26, 2021 |
| FBN Securities | Shebly Seyrafi | $310 | $267.79 | +25.1% | Aug 26, 2021 |
| Bernstein | Mark Moerdler | $290 | $267.79 | +17.1% | Aug 26, 2021 |
| KGI Securities | Freddy Chen | $330 | $267.79 | +33.2% | Aug 26, 2021 |
| Macquarie | Frederick Havemeyer | $280 | $244.27 | +13.0% | Jun 30, 2021 |
| Redburn Partners | Neil Steer | $320 | $244.57 | +29.2% | Jun 28, 2021 |
| Daiwa | Satoshi Tanaka | $285 | $237.48 | +15.0% | Jun 4, 2021 |
Track every rating change on CRM the moment it posts. Free to start.
Start free